Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated (LGND) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0000886163 · LGND · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0000886163 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1992. As a Healthcare sector company with CIK 0000886163, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Ligand Pharmaceuticals Incorporated's most comprehensive regulatory disclosure. The most recent Ligand Pharmaceuticals Incorporated 10-K was filed on 2026-02-27 for fiscal year ending 2026. Historical LGND 10-K annual reports are available from 2014 through 2026.
Investors researching Ligand Pharmaceuticals Incorporated SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
LGND SEC Filings · 8 questionsLigand Pharmaceuticals Incorporated (LGND) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Ligand Pharmaceuticals Incorporated's CIK is 0000886163.